Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer

HER-2 and the vascular endothelial factor receptor (VEGF) represent validated targets for the therapy of multiple tumor types and inhibitors of these receptors have gained increasing importance in the clinic. In this context, novel bioactive agents associated with better therapeutic outcomes and imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Bozanovic, Tatjana, Carson, William E., Kaumaya, Pravin T. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494615/
https://www.ncbi.nlm.nih.gov/pubmed/23170249
http://dx.doi.org/10.4161/onci.21057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494615/
https://www.ncbi.nlm.nih.gov/pubmed/23170249
http://dx.doi.org/10.4161/onci.21057

Ejemplares similares